首页> 外文期刊>Signal transduction and targeted therapy. >Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer
【24h】

Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

机译:蛋白质甲基转移酶SETD7调控的生物学过程和信号转导途径及其在癌症中的意义

获取原文
           

摘要

Protein methyltransferases have been shown to methylate histone and non-histone proteins, leading to regulation of several biological processes that control cell homeostasis. Over the past few years, the histone-lysine N -methyltransferase SETD7 (SETD7; also known as SET7/9, KIAA1717, KMT7, SET7, SET9) has emerged as an important regulator of at least 30 non-histone proteins and a potential target for the treatment of several human diseases. This review discusses current knowledge of the structure and subcellular localization of SETD7, as well as its function as a histone and non-histone methyltransferase. This work also underlines the putative contribution of SETD7 to the regulation of gene expression, control of cell proliferation, differentiation and endoplasmic reticulum stress, which indicate that SETD7 is a candidate for novel targeted therapies with the aim of either stimulating or inhibiting its activity, depending on the cell signaling context.
机译:蛋白质甲基转移酶已被证明可甲基化组蛋白和非组蛋白,从而导致控制细胞稳态的几种生物学过程的调控。在过去的几年中,组蛋白赖氨酸N-甲基转移酶SETD7(SETD7;也称为SET7 / 9,KIAA1717,KMT7,SET7,SET9)已成为至少30种非组蛋白的重要调节剂和潜在靶标用于治疗几种人类疾病。这篇综述讨论了SETD7的结构和亚细胞定位的当前知识,以及其作为组蛋白和非组蛋白甲基转移酶的功能。这项工作还强调了SETD7在调节基因表达,控制细胞增殖,分化和内质网应激方面的可能贡献,这表明SETD7是新型靶向疗法的候选者,目的是刺激或抑制其活性,具体取决于在小区信令上下文中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号